BRI.Tech GMBH
Graz
About BRI.Tech GMBH
BRI.Tech is breaking new ground in orthopedic and trauma surgery by making a second surgical intervention unnecessary with biodegradable magnesium. The main idea behind BRI.Tech is all about the treatment of broken bones in children. In dealing with fractures, the use of a stabilizing implant is often unavoidable – and then, after a period of approximately six weeks, when bone healing is in a final state, a second operation is necessary to remove the implant from the growing skeleton. This, obviously, always constitutes a risk and might require another unpleasant hospital stay. Thus, developing a stable implant that dissolves naturally as soon as the bone is able to take over the load again is a major step towards avoiding pain and discomfort. BRI.Tech’s intention is to avoid surgical interventions for implant removal, which helps to reduce costs for the European healthcare system. BRI.Screw is the result of eight years of preclinical research, combined with state-of-the-art materials. BRI.Screw is there to stabilize a fractured bone as long as it is needed in order to support it. Unlike conventional implants, its material dissolves naturally and is excreted by the body as soon as the bone is fully functional again. BRI.Tech was founded in 2016 and is a start-up company located in Graz, Austria.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $52.7K
- Last round: Grant (Mar 2017)
- Website: britech.eu
- Phone: +43 660 5094372
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/bri-tech-gmbh-2238107 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.